What is LifeMD Inc (LFMD) stock price today?

LifeMD Inc (LFMD) currently trades at $4.68 per share. The stock has a market capitalization of $216.37M and a P/E ratio of —x.

Is LFMD stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, LifeMD Inc has a Smart Value Score of 25/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is LifeMD Inc's revenue and earnings?

LifeMD Inc has trailing twelve-month (TTM) revenue of $194.06M with profit margins of 7.40%. Earnings per share (EPS) is $-0.30.

Is LFMD stock overvalued or undervalued?

Based on our DCF model, LifeMD Inc's intrinsic value is $17.58, representing a margin of safety of 83.45%. The stock currently trades at a P/E of —x.

LFMD

LifeMD Inc

NASDAQ: LFMD · HEALTHCARE · HEALTH INFORMATION SERVICES

$4.68

+5.64% today

Updated 2026-04-30

Market cap

$216.37M

P/E ratio

—

P/S ratio

1.12x

EPS (TTM)

$-0.30

Dividend yield

—

52W range

$3 – $16

Volume

1.3M

Market cap

$216.37M

P/E ratio

—

P/S ratio

1.12x

EPS (TTM)

$-0.30

Dividend yield

—

52W range

$3 – $16

Volume

1.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.7

Growth

5.0

Quality

C+

2.5

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$9.88

+111.11%

12-Month target

—

Intrinsic (DCF)

$17.58

Margin of safety

+83.45%

0 Strong Buy8 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ 83.45% below intrinsic value

Risks

- Negative free cash flow $-3.44M

- Revenue declining -27.10% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$119.03M	$152.55M	$212.45M	$194.06M	$194.06M
Net income	$-45.54M	$-20.60M	$-18.88M	$-7.11M	$-1.50M
EPS	—	—	—	—	$-0.30
Free cash flow	$-35.83M	$86948.00	$5.98M	$6.41M	$-3.44M
Profit margin	-38.25%	-13.50%	-8.89%	-3.66%	7.40%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
LFMD	$216.37M	25	4.7	2.5	6.7	5.0	+83.45%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

LifeMD Inc trades at $4.68. Our Smart Value Score of 25/100 indicates the stock is weak. TTM revenue stands at $194.06M. with profit margins at 7.40%. Our DCF model estimates intrinsic value at $17.58.

Frequently asked questions

What is LifeMD Inc's stock price?

LifeMD Inc (LFMD) trades at $4.68.

Is LifeMD Inc overvalued?

Smart Value Score 25/100 (Grade F, Strong Sell). DCF value $17.58.

What is the price target of LifeMD Inc (LFMD)?

The analyst target price is $9.88, representing +111.1% upside from the current price of $4.68.

What is the intrinsic value of LifeMD Inc (LFMD)?

Based on our DCF model, intrinsic value is $17.58, a +83.5% margin of safety versus $4.68.

What is LifeMD Inc's revenue?

TTM revenue is $194.06M.

Company info

SectorHEALTHCARE

IndustryHEALTH INFORMATION SERVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio1.12x

ROE-131.20%

Beta1.77

50D MA$3.63

200D MA$5.18

Shares out0.05B

Float0.04B

Short ratio—

Avg volume1.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

LFMD vs LLY →LFMD vs JNJ →LFMD vs ABBV →Stock screener →